Molecular control of lymphatic metastasis

Area of Science:

• Oncology
• Molecular Biology
• Cancer Metastasis Research

Background:

• Metastatic spread of tumor cells via lymphatic vasculature is a lethal aspect of cancer.
• Tumor lymphangiogenesis, the growth of lymphatic vessels near tumors, correlates with lymph node metastasis.
• Altered adhesive properties of lymphatic endothelium near tumors may facilitate lymphatic metastasis.

Purpose of the Study:

• To provide an overview of molecular mechanisms controlling lymphatic metastasis.
• To discuss potential therapeutic strategies for inhibiting lymphatic metastasis in cancer.
• To highlight the role of lymphangiogenic growth factors in promoting tumor lymphatic growth and metastasis.

Main Methods:

• Review of experimental tumor models and human clinicopathologic data.
• Analysis of molecular signaling pathways involved in lymphangiogenesis and lymphatic metastasis.
• Discussion of identified lymphangiogenic growth factors and their receptors.

Main Results:

• Vascular Endothelial Growth Factor-C (VEGF-C) and VEGF-D promote tumor lymphangiogenesis and metastasis via VEGF Receptor-3 (VEGFR-3).
• Other factors like VEGF-A, PDGF-BB, and HGF also implicated in lymphangiogenesis and lymphatic metastasis.
• Tumor-secreted factors can induce lymphangiogenesis in lymph nodes preceding tumor cell arrival, facilitating metastasis.

Conclusions:

• Understanding molecular mechanisms of lymphatic metastasis is crucial for developing targeted therapies.
• VEGF-C and VEGF-D are key drivers of tumor lymphangiogenesis and lymphatic metastasis.
• Targeting lymphangiogenic pathways presents a promising therapeutic approach to combat cancer metastasis.